> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# 3 Not Marketed Animal Drugs Withdrawn
- URL: https://www.fdaweb.com/3-not-marketed-animal-drugs-withdrawn/
- Published: 2020-01-27T12:00:00.000Z
- Updated: 2026-09-14T16:00:09.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5145927

*Federal Register* notice: FDA has withdrawn approval of a new animal drug application and two abbreviated new animal drug applications at the sponsors’ request because they are no longer manufactured or marketed. The products are Fleming Laboratories’ NADA for Wazine (dipiperazine sulfate and piperazine HCl); Halocarbon Products ANADA for halothane; and Mylan Institutional’s ANADA fomepizole. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2020-01-24/pdf/2020-00422.pdf?ref=fdaweb.com).